Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Utility of Insulin Glargine (Lantus) Compared to NPH in Ethnic Minority Type 2 Diabetic Subjects on Combination Insulin-Oral Agent Therapy

NCT00687453 is registered in ClinicalTrials.gov with Charles Drew University of Medicine and Science as lead sponsor.

NCT NCT00687453
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00687453 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Utility of Insulin Glargine (Lantus) Compared to NPH in Ethnic Minority Type 2 Diabetic Subjects on Combination Insulin-Oral Agent Therapy
Lead sponsor
Charles Drew University of Medicine and Science
Phase
Phase 4
Overall status
Terminated
Start date
February 28, 2003
Completion date
August 31, 2009
Enrollment
27 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes mellitus